News

16 Mar 2020
JZ Capital announces tender offer

JZ Capital Partners secondary sale delayed

JZ Capital Partners (JZCP) has said that in light of the covid-19 outbreak, the previously announced US secondary sale has been delayed. Whilst the duration and impact of COVID-19 is uncertain at this time, the company remains committed to its strategy of realising value from its investment portfolio including via the secondary sale, and to […]

16 Mar 2020

Update from CVC Credit Partners European Opportunities

CVC Credit Partners European Opportunities (CCPE/CCPG) has released this update: “Following our 2nd March note addressing the initial impact of the Coronavirus outbreak, global credit markets have continued to experience significant volatility in the past weeks, driven by (i) the continued expansion of the coronavirus epidemic on a global scale, and (ii) the break-up of […]

16 Mar 2020

QuotedData’s other news 16 March 2020

In QuotedData’s other news 16 March 2020 – RDL Realisation (RDL) provided the following update on the Princeton fund: “on Friday 13 March 2020, the United States bankruptcy court entered an order confirming the Fifth Amended Chapter 11 Plan proposed by the Chapter 11 Trustee in the Princeton alternative income fund bankruptcy case. The plan was […]

13 Mar 2020

Master Investor – the UKs largest private investor show – moved to 5 December 2020

In light of cov-19, it has been announced this afternoon that Master Investor, the UKs largest private investor show, has been moved to Saturday 5 December 2020. The event was originally scheduled for Saturday  28 March 2020. Click on the following link for more information: https://quoteddata.com/events/master-investor-uks-largest-private-investor-show/  

13 Mar 2020

QuotedData reflects on Augmentum Fintech’s capital markets day

From time-to-time, QuotedData’s analysts meet a wide range of companies that aren’t clients of our sponsored research service. We figure it makes sense to share some of our thoughts on these companies with you. Here are some observations from a recent capital markets day hosted by Augmentum Fintech (AUGM), at Plaisterers’ Hall, One London Wall. AUGM […]

13 Mar 2020

Fourth acquisition from US Solar as it gets closer to full deployment of $200m IPO proceeds

US Solar (USF) announced it has closed the acquisition of 100% of the cash equity interests in a portfolio of twenty-two operating utility-scale solar power projects totalling approximately 177MWDC in North Carolina, Oregon, and California. USF announced signing of the binding transaction on 29 January 2020 with closing subject to customary conditions and consents which have now […]

13 Mar 2020

Stock selection drives strong results from European Assets

Part of the European smaller companies sector, European Assets (EAT) has released its annual results to end-December 2019. In sterling terms, the share price and NAV total returns came in at 25.7% and 19.8%, with stock selection driving performance (sector allocation detracted slightly). The best performance came from ASM International, the Dutch listed semiconductor equipment supplier, […]

13 Mar 2020

Aberdeen Smaller Companies delivers a strong set of 2019 results

Aberdeen Smaller Companies (ASCI), which invests in UK smaller companies, has reported annual results to 31 December 2019. The company’s performance in NAV and share price terms, as well as that of its benchmark, is shown below: NAV total return FTSE Small Cap ex Inv Trust Index total return Share price total return 2019: +34.4% […]

13 Mar 2020

JPEL Private Equity announces portfolio sale

JPEL Private Equity (JPEL) announced a partial sale in JPEL’s 2nd largest portfolio company, a tax advisory services company. At 31 December 2019, the company represented 18.7% of JPEL’s private equity portfolio value. The partial realisation results in an investment return of approximately 4.39x and an IRR of approximately 33% for JPEL.  As part of the transaction, JPEL […]

10 Mar 2020

BioPharma Credit significantly increased its scale over 2019

BioPharma Credit (BPCR) has published annual results to 31 December 2019. The company says it is London’s only specialist debt investor to the life sciences industry. The company seeks to achieve returns for its shareholders primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences […]